与免疫检查点抑制剂治疗相关的心血管毒性:综合性审查
Mandana Chitsazan1, Ahmad Amin2, Luisa Ladel1
1From the Department of Medicine, Norwalk Hospital, Norwalk, CT.
免疫检查点抑制剂 (ICI) 可以导致严重的心血管毒性,包括心肌炎和心律失常. 及时诊断和多学科管理对于接受ICI癌症治疗的患者至关重要.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 是一种革命性的癌症治疗方法,可以增强对瘤的免疫反应.
- 然而,ICI可以诱导与免疫相关的不良影响,特别是心血管毒性,如心肌炎,心心膜炎,心律失常和血管炎.
- 这些心血管并发症可能是严重和危及生命的,需要仔细监测.
结论:
- ICI疗法在癌症治疗中提供了显著的好处,但会带来心血管不良事件的风险.
- 需要进一步的研究来阐明潜在的机制,并开发预测性生物标志物.
- 优化患者护理需要全面了解和主动管理ICI相关的心血管并发症.
更多相关视频
06:07Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood
Published on: February 5, 2020
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis III: Medical Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
